Richtlijn CVRM feb2013 - KNMP

Haafkens 2011 Haafkens JA et al. Onder hoge druk II: Evaluatie van een cultuurspecifiek
voorlichtingsprogramma ter bevordering van leefstijlveranderingen en therapietrouw bij
Surinaamse en Ghanese patienten met hoge bloeddruk. Project ZonMW
Preventieprogramma 4, dossiernummer 122000008. . ( www.zonmw.nl/nl/projecten/
project-detail/onder-hoge-druk-ii-evaluatie-van-een-cultuurspecifiek-programma-terbevordering-van-l/voortgang/)
Haafkens 2009 Haafkens JA, Beune EJ, Moll van Charente EP, Agyemang CO. A cluster-randomized controlled
trial evaluating the effect of culturally-appropriate hypertension education among Afro-
Surinames and Ghanaian patients in Dutch general practice: study protocol. BMC Health Serv
2009; 9: 193.
Afro-
Res
Haak vd 2010 Van den Haak P, Heintjes E, Plat AW, Meerding WJ, Webb K, Sturkenboom MC en
Herings RMC. Determination of non-treatment with statins of high risk patients in the
Netherlands. Curr Med Res & Opin 2010; 26: 271-278.
Hackam 2011 Hackam DG, Woodward M, Newby LK, Bhatt DL, Shao M, Smith EE. Et al. Statins and
intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation 2011;
PMID: 22007076.
Hackam 2012 Hackam DG, Austin PC, Huang A, Juurlink DN, Mamdami MM, Paterson JM, et al. Statins and
intracerebral hemorrhage. A retrospecctive cohort study. Arch Neurol 2012; 69 (1): 39-45.
Hagen 1994 Hagen E, Istad H, Ose L, Bodd E, Eriksen HM, Selvig V, et al. Fluvastatin efficacy and
tolerability in comparison and in combination with cholestyramine. Eur J Clin Pharmacol.
1994;46(5):445-9.
Huijgen 2010 Huijgen R, Abbink EJ, Bruckert E, Stalenhoef AF, Imholz BP, Durrington PN, et al. Triple Study
Group. Colesevelam added to combination therapy with a statin and ezetimibe in patients
with
familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind,
controlled trial. Clin
Ther. 2010 Apr;32(4):615-25.
Hallas 2006 Hallas J, Dall M, Andries A, Sogaard Andersen B, Aalykke C, Moller Hansen J, et al. Use of
single and combined antothrombotic therapy and risk of serious upper gastrointestinal
bleeding: population based case-control study. BMJ 2006; 333: 726.
Halkes 2006
Halkes PH, Van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin
alone after cerebral ischeamia of arterial origin ( ESPRIT): randomised controlled trial. Lancet 2006;
367: 1665 - 73.
Halbert 2010 Halbert SC, French B, Gordon RY, et al. Tolerability of red yeast rice (2,400 mg twice daily)
versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. Am J
Cardiol. 2010;105(2):198–204.
Hansson 1999
Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, et al. Effect of angiotensinconverting-enzyme
inhibition compared with conventional therapy on cardiovascular morbidity and
mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999;
353: 611-616.
Hansson 2000 Hansson L, Hedner T, Lund-Johanen P, Kjeldsen SE, Lindholm LH, Syvertsen JO, Lanke J, de Faire U,
Dahlöf B Karlberg BE. Randomised trial of calcium antagonists compared with diuretics and betablockers
on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL)
study. Lancet 2000; 356: 359-365.
Harper 2010 Harper CR, jacobson TA. Evidence based management of statin myopathy. Curr Atheroscler
Rep. 2010; 12 (5): 322-30.
Harper 2012 Harper P, et al.Bleeding risk with dabigatran in the frail elderly [correspondence].
N Engl J Med 2012; 366: 864-866.
Hartst website a Hartstichting website. http://www.hartstichting.nl/actueel/feiten_en_cijfers/ geraadpleegd op 18-
1-2013.
Hartst website b Hartstichting website. http://www.hartstichting.nl/risicofactoren/
hoog_cholesterol/erfelijk_hoog_cholesterol/ geraadpleegd op 18-1-2013.
89
CONCEPT